PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
Figure 1
Effect of a PPARγ agonist on in vitro growth of thyroid cancer cell lines. Cells (denoted on the -axis) were treated with vehicle (DMSO), or Rosi (1 μM or 10 μM) every 3 days for 6 days. The effect of treatment on proliferation was determined by automated viable cell counting. Data is represented as percent viable cells/mL compared to vehicle, which is denoted by the dashed line. Mean ± S.E.M. of at least 3 independent experiments performed in duplicate is reported (*, when compared to vehicle control).
